98 related articles for article (PubMed ID: 8139380)
1. Scopolamine effects on the pressor response to thyrotropin-releasing hormone in humans.
Molchan SE; Hill JL; Minichiello M; Vitiello B; Sunderland T
Life Sci; 1994; 54(13):933-8. PubMed ID: 8139380
[TBL] [Abstract][Full Text] [Related]
2. TRH attenuates scopolamine-induced memory impairment in humans.
Molchan SE; Mellow AM; Lawlor BA; Weingartner HJ; Cohen RM; Cohen MR; Sunderland T
Psychopharmacology (Berl); 1990; 100(1):84-9. PubMed ID: 2104988
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's disease.
Mellow AM; Sunderland T; Cohen RM; Lawlor BA; Hill JL; Newhouse PA; Cohen MR; Murphy DL
Psychopharmacology (Berl); 1989; 98(3):403-7. PubMed ID: 2501817
[TBL] [Abstract][Full Text] [Related]
4. Pressor, norepinephrine, and pituitary responses to two TRH doses in Alzheimer's disease and normal older men.
Lampe TH; Veith RC; Plymate SR; Risse SC; Kopeikin H; Cubberley L; Raskind MA
Psychoneuroendocrinology; 1989; 14(4):311-20. PubMed ID: 2510210
[TBL] [Abstract][Full Text] [Related]
5. The involvement of central cholinergic mechanisms in cardiovascular responses to intracerebroventricular and intravenous administration of thyrotropin-releasing hormone.
Okuda C; Mizobe T; Miyazaki M
Life Sci; 1987 Mar; 40(13):1293-9. PubMed ID: 3104710
[TBL] [Abstract][Full Text] [Related]
6. The effects of thyrotropin-releasing hormone and scopolamine in Alzheimer's disease and normal volunteers.
Molchan SE; Mellow AM; Hill JL; Weingartner H; Martinez R; Vitiello B; Sunderland T
J Psychopharmacol; 1992 Jan; 6(4):489-500. PubMed ID: 22291397
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of the pressor response to intravenous thyrotropin-releasing hormone in the rat.
Evequoz D; Burnier M; Niederberger M; Brunner HR; Nussberger J; Waeber B
Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):93-100. PubMed ID: 8039276
[TBL] [Abstract][Full Text] [Related]
8. Thyrotropin-releasing hormone given intrathecally to the rat increases arterial pressure and heart rate.
Yashpal K; Gauthier S; Henry JL
Circ Res; 1989 Oct; 65(4):859-68. PubMed ID: 2551531
[TBL] [Abstract][Full Text] [Related]
9. The acute cardiovascular actions of intravenous thyrotrophin releasing hormone (TRH) in man are mediated by non-catecholaminergic mechanisms.
Bouloux PM; Corsello S; Besser M; Grossman A
Br J Clin Pharmacol; 1996 Aug; 42(2):225-32. PubMed ID: 8864322
[TBL] [Abstract][Full Text] [Related]
10. Thyrotropin-releasing hormone produces different hemodynamic effects in vegetative and brain-dead patients.
Aibiki M; Shirakawa Y; Ogura S; Uefuji T; Seki K; Umegaki O; Ogli K
Clin Neuropharmacol; 1993 Oct; 16(5):428-37. PubMed ID: 8221703
[TBL] [Abstract][Full Text] [Related]
11. Central muscarinic cholinergic antagonists block wet-dog shakes produced by the TRH analog MK-771 in the rat.
Sills MA; Mellow AM; Sunderland T; Jacobowitz DM
Brain Res; 1988 Jun; 453(1-2):385-8. PubMed ID: 3135919
[TBL] [Abstract][Full Text] [Related]
12. Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study.
Sunderland T; Tariot PN; Cohen RM; Weingartner H; Mueller EA; Murphy DL
Arch Gen Psychiatry; 1987 May; 44(5):418-26. PubMed ID: 3579494
[TBL] [Abstract][Full Text] [Related]
13. Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents.
Miyamoto M; Hirai K; Takahashi H; Kato K; Nishiyama M; Okada H; Nagaoka A
Eur J Pharmacol; 1993 Jul; 238(2-3):181-9. PubMed ID: 8405091
[TBL] [Abstract][Full Text] [Related]
14. Sympathetic vasoconstriction and renin secretion cause pressor responses to thyrotropin-releasing hormone in rats.
Mattila J; Buñag RD
J Pharmacol Exp Ther; 1986 Jul; 238(1):232-6. PubMed ID: 3088259
[TBL] [Abstract][Full Text] [Related]
15. Sympathomimetic pressor responses to thyrotropin-releasing hormone in rats.
Mattila J; Buñag RD
Am J Physiol; 1986 Jul; 251(1 Pt 2):H86-92. PubMed ID: 3089031
[TBL] [Abstract][Full Text] [Related]
16. Serotonergic involvement in the cardiovascular stimulation by thyrotropin-releasing hormone (TRH) in anesthetized rats.
Nurminen ML; Paakkari I; Seppälä T
Neurosci Lett; 1991 Jun; 127(2):147-9. PubMed ID: 1715540
[TBL] [Abstract][Full Text] [Related]
17. EEG and blood pressure effects of TRH in rabbits.
Beale JS; White RP; Huang SP
Neuropharmacology; 1977; 16(7-8):499-506. PubMed ID: 411053
[No Abstract] [Full Text] [Related]
18. Adverse cardiovascular responses to thyrotropin-releasing hormone (200 micrograms) in cardiac patients.
Sobel RJ; Ariad S
Isr J Med Sci; 1987 Nov; 23(11):1107-9. PubMed ID: 3125128
[TBL] [Abstract][Full Text] [Related]
19. Effects of intracerebroventricular administration of thyrotrophic-releasing hormone on cardiovascular function in the rat.
Tsay BL; Lin MT
Neuroendocrinology; 1982; 35(3):173-7. PubMed ID: 6813757
[TBL] [Abstract][Full Text] [Related]
20. Low-dose thyrotropin-releasing hormone effects in cognitively impaired alcoholics.
Khan A; Mirolo MH; Claypoole K; Hughes D
Alcohol Clin Exp Res; 1993 Aug; 17(4):791-6. PubMed ID: 8214416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
